report
What can we expect from Turkiye’s health sector?
What can we expect from Turkiye’s health sector?
Persistent economic instability remains a key constraint.
Cytogenetics market to be valued at $5.5b by 2031
Its growth is attributed to the rising prevalence of genetic disorders and cancer.
Healthcare payers lag in digital maturity: report
AI solutions could cut costs and increase revenue for payers.
Alzheimer's drugs market to be valued at $16.43b by 2033
Technologies like genomics, neuroimaging, and biomarker analysis drive growth.
Global infertility treatment devices to hit $2.5b by 2032
Its growth is attributed to ongoing innovation, particularly in AI integration.
Global medical radioisotopes market to be valued at $1.38b by 2034
Thanks to rising applications in diagnostics and therapeutics.
AI to enhance cardiovascular diagnostics amidst worker shortage
A heart ultrasound may take up to 90 minutes and requires expert interpretation.
Medical software market to surpass $120b by 2034
However, limited awareness and high upfront costs may hinder growth.
Global traditional wound care market to hit $9.12b by 2030
Its growth is attributed to rising cases of traumatic and burn injuries.
Digital platforms to enhance predictive modelling, personalised care
One key driver includes patient data integration into mobile health platforms.
Global medical drones market to reach $1.2b by 2032
Thanks to the rising need for quicker transportation of medical services.
Global patient portals market to reach $8.38b by 2030
Thanks to collaborations between new entrants and major software vendors.
Medical device firms eye sustainability amidst regulatory changes
Regulatory shifts may lead to temporary device shortages in the short term.
India’s diagnostic imaging market to exceed $7b by 2033
Thanks to rising healthcare expenditure and a greater demand for accessible solutions.
Medical alert systems market to double by 2032
Thanks to product performance innovations and AI integration.
Global central nervous system market to surpass $80b in 2025
It is the fifth-fastest growing therapy area for the year.
Japan’s 10-year fund to boost pharmaceutical landscape
The country’s ageing population is driving demand for innovative treatments.